TITLE

Faced with a progressive lesion

AUTHOR(S)
Kirby, Philip
PUB. DATE
May 1996
SOURCE
Cortlandt Forum;5/25/96, Vol. 9 Issue 5, p183
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents the case of a 27-year-old woman diagnosed with discoid lupus erythematosus. Appearance of a persistent, growing red lesion on patient's left cheek; Result of biopsy for histology and immunofluorescence; Treatment with hydroxychloroquine.
ACCESSION #
9605234576

 

Related Articles

  • Ethosuximide-associated lupus with cerebral and renal manifestations. Casteels, K.; Van Geet, C.; Wouters, K. // European Journal of Pediatrics;1998, Vol. 157 Issue 9, p780 

    Presents information on the clinical case of an 11-year-old girl with ethosuximide associated systemic lupus erythematosus. Results of the laboratory investigation; Analysis of urine samples; Relationship between anticonvulsants and the appearance of lupus.

  • Adalimumab.  // Reactions Weekly;11/17/2012, Issue 1428, p5 

    The article describes the case of a patient with rheumatoid arthritis who developed adalimumab-induced lupus erythematosus revealed by interstitial granulomatous dermatitis.

  • Lupus Out Loud encourages patients to speak up. Laraque, Amber Tafari // New York Amsterdam News;5/31/2012, Vol. 103 Issue 22, p29 

    The article presents information on the launching of an online movement Lupus Out Loud for encouraging the patients of lupus to speak up and express all of their symptoms to their doctors.

  • TMA in Setting of LN May Be Associated with Circulating Antiphospholipid Antibody. Charney, D.A.; Nassar, G.; Truong, L. // Kidney;Nov/Dec2000, Vol. 9 Issue 6, p250 

    Focuses on a study which presented case reports of diffuse proliferative and necrotizing glomerulonephritis in patients with systemic lupus erythematosus or lupus-like syndrome. Methodology; Results; Conclusion.

  • Chilblain lupus erythematosus is associated with antibodies to SSA/Ro. Franceschini, F.; Calzavara-Pinton, P.; Quinzanini, M.; Cavazzana, I.; Bettoni, L.; Zane, C.; Facchetti, F.; Airò, P.; McCauliffe, D.P.; Cattaneo, R. // Lupus;1999, Vol. 8 Issue 3, p215 

    Chilblain lupus erythematosus (CL) of Hutchinson is a subtype of lupus erythematosus (LE) characterized by erythematous lesions induced by cold, damp climates. A number of patients affected by CL eventually develop features of systemic lupus erythematosus (SLE). We report here 9 patients with...

  • The Prognosis of Lupus Nephritis. Zwelman, Burion; Kornblum, Joan; Cornog, John; Hildrehl, Eugene A. // Annals of Internal Medicine;Sep68, Vol. 69 Issue 3, p441 

    Presents a study that compared the clinical and histologic renal findings at the time of initial evaluation of patients with systemic lupus erythematosis. Lack of correlation between the presence or absence of clinical renal abnormalities; Performance of individuals without renal involvement by...

  • Stress, depression, and anxiety predict average symptom severity and daily symptom fluctuation in... Adams Jr., Serrhel G.; Dammers, Paul M. // Journal of Behavioral Medicine;Oct94, Vol. 17 Issue 5, p459 

    Examines the relationship between stress, depression, anxiety, anger and systemic lupus erythematosus (SLE) symptom complaints. Prediction of symptom history; Correlations with the severity of SLE symptoms; Variability in the strength of stress-illness relation; Exacerbation of self-reported...

  • Treatment needed to achieve remission of SLE. Alarcón-Segovia, Donato // Lupus;1999, Vol. 8 Issue 7, p1 

    Contends that patients with systemic lupus erythematosus can achieve remission. Increase in the probability of achieving remission as the disease lasts longer; Treatment required for achieving remission.

  • Pustuloderma during cutaneous lupus treatment with thalidomide. Rúa-Figueroa, I.; Erausquin, C.; Naranjo, A.; Carretero-Hernández, G.; Rodriguez-Lozano, C.; de la Rosa, P. // Lupus;1999, Vol. 8 Issue 3, p248 

    Reports on a case of toxic pustuloderma secondary to the thalidomide drug in a patient with refractory cutaneous lupus erythematosus. Side effects of the thalidomide hypnosedative drug; Characteristics of toxic pustuloderma; Types of bullous lesions in patients with systemic lupus erythematosus.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics